SNX7

• Description:

  SNX7 is a Cyclin-Dependent Kinase Inhibitor (CDKI) pathway inhibitor. SNX7 can be used for research of senescence-related and other CDKI-related diseases[1].

• UNSPSC:

  12352005

• Target:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/snx7.html

• Purity:

  99.89

• Solubility:

  DMSO : 250 mg/mL (ultrasonic)

• Smiles:

  CCN1C2=C(C=CC=C2)N=C1/C=C/C3=CC=CO3

• Molecular Formula:

  C15H14N2O

• Molecular Weight:

  238.28

• References & Citations:

  [1]Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent. US20090281129.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, protect from light)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [685097-43-2]